Metraipolis › archive › dc_e7fc2fe7388b

Sequential CDK4/6 inhibition in bone-only metastatic HR+/HER2- breast cancer: a case of prolonged disease control with abemaciclib after clinical progression… — Europe PMC PMID:42210941

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42210941
DOI
10.3389/fmed.2026.1775724
License (as archived)
solo-consultazione
Archived
2026-11-02T14:32:03.688Z
SHA-256 of the archived text
3e2733eec2f50aadfac41ee87c77da0ebacc9660a7a545e849a8133e886e8e69
Stable URL of this page
https://metraipolis.com/documento/dc_e7fc2fe7388b

How to cite

Sequential CDK4/6 inhibition in bone-only metastatic HR+/HER2- breast cancer: a case of prolonged disease control with abemaciclib after clinical progression… — Europe PMC PMID:42210941 — Europe PMC (en), https://europepmc.org/article/MED/42210941 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_e7fc2fe7388b (Metraipolis archive dc_e7fc2fe7388b, sha256 3e2733eec2f50aadfac41ee87c77da0ebacc9660a7a545e849a8133e886e8e69)
BibTeX
@misc{dce7fc2fe7388b,
  title = {Sequential CDK4/6 inhibition in bone-only metastatic HR+/HER2- breast cancer: a case of prolonged disease control with abemaciclib after clinical progression… — Europe PMC PMID:42210941},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42210941},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_e7fc2fe7388b; sha256 3e2733eec2f50aadfac41ee87c77da0ebacc9660a7a545e849a8133e886e8e69},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42210941. Agents can read the archived copy with the MCP tool read_document.